304 related articles for article (PubMed ID: 24987060)
21. Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.
Popovic R; Martinez-Garcia E; Giannopoulou EG; Zhang Q; Zhang Q; Ezponda T; Shah MY; Zheng Y; Will CM; Small EC; Hua Y; Bulic M; Jiang Y; Carrara M; Calogero RA; Kath WL; Kelleher NL; Wang JP; Elemento O; Licht JD
PLoS Genet; 2014 Sep; 10(9):e1004566. PubMed ID: 25188243
[TBL] [Abstract][Full Text] [Related]
22. PRC2 mediated H3K27 methylations in cellular identity and cancer.
Conway E; Healy E; Bracken AP
Curr Opin Cell Biol; 2015 Dec; 37():42-8. PubMed ID: 26497635
[TBL] [Abstract][Full Text] [Related]
23. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.
Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L
Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428
[TBL] [Abstract][Full Text] [Related]
24. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.
Lee SW; Park DY; Kim MY; Kang C
Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835
[TBL] [Abstract][Full Text] [Related]
25. Study of methylation of histone H3 lysine 9 and H3 lysine 27 during X chromosome inactivation in three types of cells.
Li Y; Tan T; Zong L; He D; Tao W; Liang Q
Chromosome Res; 2012 Aug; 20(6):769-78. PubMed ID: 22956184
[TBL] [Abstract][Full Text] [Related]
26. A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylation.
Ott HM; Graves AP; Pappalardi MB; Huddleston M; Halsey WS; Hughes AM; Groy A; Dul E; Jiang Y; Bai Y; Annan R; Verma SK; Knight SD; Kruger RG; Dhanak D; Schwartz B; Tummino PJ; Creasy CL; McCabe MT
Mol Cancer Ther; 2014 Dec; 13(12):3062-73. PubMed ID: 25253781
[TBL] [Abstract][Full Text] [Related]
27. Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression.
Jain SU; Khazaei S; Marchione DM; Lundgren SM; Wang X; Weinberg DN; Deshmukh S; Juretic N; Lu C; Allis CD; Garcia BA; Jabado N; Lewis PW
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27354-27364. PubMed ID: 33067396
[TBL] [Abstract][Full Text] [Related]
28. DISORDERED HISTONE METHYLATION IN HEMATOLOGICAL MALIGNANCIES THE CASE OF UTX/KDM6A.
Licht JD
Trans Am Clin Climatol Assoc; 2018; 129():24-36. PubMed ID: 30166694
[TBL] [Abstract][Full Text] [Related]
29. Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors.
Huang X; Yan J; Zhang M; Wang Y; Chen Y; Fu X; Wei R; Zheng XL; Liu Z; Zhang X; Yang H; Hao B; Shen YY; Su Y; Cong X; Huang M; Tan M; Ding J; Geng M
Cell; 2018 Sep; 175(1):186-199.e19. PubMed ID: 30220457
[TBL] [Abstract][Full Text] [Related]
30. EZH2-Targeted Therapies in Cancer: Hype or a Reality.
Eich ML; Athar M; Ferguson JE; Varambally S
Cancer Res; 2020 Dec; 80(24):5449-5458. PubMed ID: 32978169
[TBL] [Abstract][Full Text] [Related]
31. Menin mediates epigenetic regulation via histone H3 lysine 9 methylation.
Yang YJ; Song TY; Park J; Lee J; Lim J; Jang H; Kim YN; Yang JH; Song Y; Choi A; Lee HY; Jo CH; Han JW; Kim ST; Youn HD; Cho EJ
Cell Death Dis; 2013 Apr; 4(4):e583. PubMed ID: 23579270
[TBL] [Abstract][Full Text] [Related]
32. The Histone Demethylase UTX Promotes Brown Adipocyte Thermogenic Program Via Coordinated Regulation of H3K27 Demethylation and Acetylation.
Zha L; Li F; Wu R; Artinian L; Rehder V; Yu L; Liang H; Xue B; Shi H
J Biol Chem; 2015 Oct; 290(41):25151-63. PubMed ID: 26306033
[TBL] [Abstract][Full Text] [Related]
33. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.
Yap DB; Chu J; Berg T; Schapira M; Cheng SW; Moradian A; Morin RD; Mungall AJ; Meissner B; Boyle M; Marquez VE; Marra MA; Gascoyne RD; Humphries RK; Arrowsmith CH; Morin GB; Aparicio SA
Blood; 2011 Feb; 117(8):2451-9. PubMed ID: 21190999
[TBL] [Abstract][Full Text] [Related]
34. Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells.
Hino S; Kohrogi K; Nakao M
Cancer Sci; 2016 Sep; 107(9):1187-92. PubMed ID: 27375009
[TBL] [Abstract][Full Text] [Related]
35. H3K36 methylation antagonizes PRC2-mediated H3K27 methylation.
Yuan W; Xu M; Huang C; Liu N; Chen S; Zhu B
J Biol Chem; 2011 Mar; 286(10):7983-7989. PubMed ID: 21239496
[TBL] [Abstract][Full Text] [Related]
36. Lysine 27 of replication-independent histone H3.3 is required for Polycomb target gene silencing but not for gene activation.
Leatham-Jensen M; Uyehara CM; Strahl BD; Matera AG; Duronio RJ; McKay DJ
PLoS Genet; 2019 Jan; 15(1):e1007932. PubMed ID: 30699116
[TBL] [Abstract][Full Text] [Related]
37. Loss of HP1 causes depletion of H3K27me3 from facultative heterochromatin and gain of H3K27me2 at constitutive heterochromatin.
Jamieson K; Wiles ET; McNaught KJ; Sidoli S; Leggett N; Shao Y; Garcia BA; Selker EU
Genome Res; 2016 Jan; 26(1):97-107. PubMed ID: 26537359
[TBL] [Abstract][Full Text] [Related]
38. UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition.
Ezponda T; Dupéré-Richer D; Will CM; Small EC; Varghese N; Patel T; Nabet B; Popovic R; Oyer J; Bulic M; Zheng Y; Huang X; Shah MY; Maji S; Riva A; Occhionorelli M; Tonon G; Kelleher N; Keats J; Licht JD
Cell Rep; 2017 Oct; 21(3):628-640. PubMed ID: 29045832
[TBL] [Abstract][Full Text] [Related]
39. Histone demethylase UTX counteracts glucocorticoid deregulation of osteogenesis by modulating histone-dependent and -independent pathways.
Wang FS; Lian WS; Lee MS; Weng WT; Huang YH; Chen YS; Sun YC; Wu SL; Chuang PC; Ko JY
J Mol Med (Berl); 2017 May; 95(5):499-512. PubMed ID: 28130569
[TBL] [Abstract][Full Text] [Related]
40. Acetylation and methylation profiles of H3K27 in porcine embryos cultured in vitro.
Marinho LSR; Rissi VB; Lindquist AG; Seneda MM; Bordignon V
Zygote; 2017 Oct; 25(5):575-582. PubMed ID: 28693635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
